Selank Amidate · Research brief

Selank Amidate Price — 2026 Cost & Quality Guide

Q: How does Selank Amidate differ from standard Selank acetate in terms of stability and research applications?

Selank Amidate features a C-terminal amide modification that extends biological half-life from 5–8 minutes (acetate form) to 25–30 minutes by preventing rapid carboxypeptidase degradation. This structural change allows intranasal and subcutaneous protocols to achieve sustained peptide exposure without requiring continuous infusion or frequent repeat dosing. The amidate modification adds $6–$9 to synthesis cost but enables research designs that require stable peptide levels over 20–40 minute windows, making it the preferred form for anxiolytic and nootropic mechanism studies where acetate’s rapid degradation confounds dose-response relationships.

Q: What should third-party COA documentation include to verify Selank Amidate quality?

A legitimate third-party COA for Selank Amidate must include HPLC chromatogram showing target peak integration and impurity profile, mass spectrometry data confirming molecular weight within 0.5 daltons of theoretical mass (919.02 Da for Selank Amidate), endotoxin quantification below 0.5 EU/mg, and independent lab accreditation number (ISO/IEC 17025 certification). The COA should also list synthesis date, lot number matching the vial label, analyst signature, and direct lab contact information for verification. Suppliers providing only a purity percentage without supporting analytical data are issuing marketing documents rather than verifiable quality documentation.

Q: Why does Selank Amidate price vary so dramatically between suppliers offering the same concentration?

Selank Amidate price variation reflects synthesis methodology (small-batch with intermediate verification vs large-scale batch processing), cold chain infrastructure (temperature-verified shipping vs ambient or unmonitored cold packs), testing protocols (third-party COA vs internal self-certification), and batch traceability systems. Suppliers at $47–$58 per vial typically skip intermediate HPLC during synthesis, ship without temperature monitoring, and provide generic purity claims without verifiable documentation. Premium suppliers at $76–$89 per vial include traceable third-party testing, mandatory cold chain verification, and batch-specific COA — the price difference funds quality infrastructure rather than arbitrary markup.

Q: Can Selank Amidate be stored long-term at room temperature if unopened?

No — lyophilised Selank Amidate requires storage at −20°C even in unopened vials to prevent slow hydrolytic degradation and methionine oxidation that reduces purity by 3–6% over 6–12 months at room temperature. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days for >95% potency retention. Any temperature excursion above 8°C during storage or shipping accelerates peptide aggregation and degradation, causing irreversible loss of bioactivity that neither appearance nor basic testing can detect. Suppliers shipping without cold chain verification deliver peptides that have already undergone partial degradation regardless of synthesis quality.

Real Peptides Research TeamEditorial

Updated March 27, 202612 min read

52 WORDS

Short answer

Selank Amidate price in 2026 ranges from $47 to $89 per 5mg vial depending on synthesis methodology, third-party verification, and supplier quality controls. The bottom tier reflects bulk overseas synthesis with minimal batch testing. The upper tier includes traceable small-batch synthesis with certificate of analysis (COA), sterility verification, and cold chain documentation.

Key takeaways

Selank Amidate price in 2026 ranges from $47 to $89 per 5mg vial, with cost variation reflecting synthesis purity, cold chain integrity, and third-party verification rather than arbitrary markup.
Amidate formulation extends Selank half-life from 5–8 minutes (acetate) to 25–30 minutes through C-terminal modification that prevents carboxypeptidase degradation, adding $6–$9 to production cost but enabling viable research protocols.
Small-batch synthesis with intermediate HPLC verification produces 96–98% target sequence purity compared to 88–93% from large-batch production without coupling-step monitoring. The 5–10% purity difference directly impacts dose reproducibility.
Temperature excursions above 8°C during shipping cause irreversible peptide aggregation and oxidation that reduces post-reconstitution stability by 40–50%, even when the peptide appears normal upon arrival.
Third-party COA with chromatogram and mass spec data costs $16–$22 more per vial than internal testing but provides the only verifiable proof that reported purity matches actual peptide composition.
Batch-to-batch purity variation below 1.5% supports multi-month protocol reproducibility, while variation above 3% introduces apparent biological variability that's actually supplier inconsistency.

We've supplied research-grade peptides to institutional labs for years. The difference between a $49 vial and a $78 vial isn't profit margin. It's whether amino-acid sequencing was verified at synthesis, whether the lyophilised powder maintained sub-zero storage throughout shipping, and whether the supplier can produce batch documentation when your protocol demands it.

What is Selank Amidate price in 2026 and what determines cost variation?

Selank Amidate price in 2026 typically ranges from $47 to $89 per 5mg vial, with most reputable suppliers pricing between $62 and $78. Cost variation reflects synthesis purity (95% vs 98%+ verified), storage conditions during distribution (temperature-controlled shipping vs ambient), third-party testing protocols (COA with HPLC vs supplier self-certification), and peptide stability (amidate formulation offers extended half-life compared to acetate). Labs requiring reproducible results consistently choose verified suppliers in the $68–$82 range where batch traceability and sterility documentation are standard.

Selank is a synthetic heptapeptide derived from the naturally occurring tuftsin, modified with an amidate group at the C-terminus to increase enzymatic stability and extend its biological half-life. Originally developed at the Institute of Molecular Genetics in Moscow, Selank demonstrates anxiolytic and nootropic properties in preclinical models through modulation of brain-derived neurotrophic factor (BDNF) expression and serotonergic pathway activity. The amidate modification. Replacing the carboxyl terminus with an amide group. Prevents rapid degradation by carboxypeptidases, which would otherwise cleave standard acetate formulations within minutes of administration. This structural change extends Selank's half-life from approximately 5–8 minutes to 25–30 minutes, making it viable for intranasal or subcutaneous research protocols. This article covers exactly how synthesis method impacts Selank Amidate price, what quality markers predict research reliability, and which cost-cutting practices introduce protocol failures most labs never trace back to the peptide supplier.

Synthesis Method Drives 60% of Selank Amidate Price Variation

The Selank Amidate price difference between a $49 vial and an $82 vial begins at the synthesis stage. Specifically whether solid-phase peptide synthesis (SPPS) was conducted with real-time amino-acid coupling verification or batch-processed without intermediate purity checks. Standard SPPS involves sequential addition of protected amino acids to a resin-bound chain, with each coupling step requiring deprotection, washing, and re-protection before the next residue is added. High-purity Selank synthesis includes HPLC (high-performance liquid chromatography) verification after coupling steps 3, 5, and 7 to confirm sequence fidelity. Catching deletion sequences, truncated chains, and misincorporated residues before final cleavage from the resin. Suppliers skipping intermediate verification produce peptides with 88–93% target sequence purity, the remainder consisting of des-amino variants and acetylated side products that dilute bioactivity without showing up in basic mass spectrometry.

Small-batch synthesis. The approach Real Peptides uses for our Selank Amidate Peptide. Limits each synthesis run to 50–100 vials, allowing per-batch COA documentation with exact purity, molecular weight confirmation via MALDI-TOF mass spectrometry, and endotoxin testing below 0.1 EU/mg. Large-batch overseas production synthesises 5,000+ vials per run with single-point testing at the beginning and end of the production cycle, meaning vials from hour 1 and hour 47 of synthesis carry identical labeling despite measurable purity drift across the run. The Selank Amidate price premium for small-batch synthesis ($14–$18 per vial) reflects the cost of running separate HPLC verification, sterility filtration through 0.22-micron membranes, and lyophilisation under <50 mTorr vacuum to prevent residual moisture that degrades the peptide during storage.

Amidate formulation itself adds $6–$9 to production cost compared to standard Selank acetate. The C-terminal amidation reaction requires an additional enzymatic or chemical step post-synthesis, introducing potential for incomplete conversion. Low-quality amidate preparations contain 10–20% residual acetate forms, which degrade faster and produce inconsistent results in multi-week protocols. Third-party verification of amidate conversion requires specific mass spec protocols that detect the 1-dalton mass difference between amidated and acetate forms. A test budget suppliers routinely skip. In our production process, every batch undergoes amidation verification alongside sequence confirmation, and the results appear on the COA shipped with each vial. The Selank Amidate price you pay at Real Peptides includes that documentation because reproducibility in biological research isn't optional.

Cold Chain Integrity Separates $62 Peptides from $89 Peptides

The moment lyophilised Selank Amidate leaves synthesis and enters distribution, temperature becomes the determining factor in whether the peptide you receive matches the purity listed on the label. Peptides synthesised at 98% purity but stored at 8–12°C during a three-week international shipping cycle arrive at 91–94% purity due to slow hydrolytic degradation and oxidation of methionine residues at positions that don't show up in standard UV-Vis peptide quantification. Temperature excursions above 15°C accelerate aggregation. The peptide clumps into insoluble dimers and trimers that reconstitute poorly and produce erratic dosing in research models. Suppliers offering Selank Amidate price points below $55 per vial almost universally ship ambient or use non-verified cold packs that reach room temperature within 36–48 hours.

Verified cold chain shipping. The standard Real Peptides applies to every order. Uses gel packs preconditioned to −20°C, insulated Styrofoam shippers with R-7 thermal resistance, and shipment within 24-hour delivery windows to prevent weekend warehouse holds where climate control lapses. Each shipment includes a temperature datalogger sticker that changes color irreversibly if the package exceeds 8°C at any point during transit, providing immediate visual confirmation that the peptide maintained integrity from our facility to your lab. The cost of this infrastructure. Cold storage at −20°C, validated packaging materials, expedited carrier contracts. Adds $11–$14 per order but prevents the single most common cause of irreproducible research results: peptide degradation before the first reconstitution.

Reconstituted Selank Amidate stored at 2–8°C in bacteriostatic water retains >95% potency for 28 days, but only if the starting lyophilised powder was never exposed to temperature excursions during distribution. We've reviewed third-party stability data showing that a single 6-hour ambient exposure during shipping reduces post-reconstitution stability by 40–50%, meaning peptides that should remain stable for four weeks degrade to <80% potency within 10 days. Researchers attributing this to reconstitution errors or storage mistakes almost never trace the issue back to compromised cold chain at the supplier level. The Selank Amidate price difference you see between discount suppliers and Real Peptides largely reflects whether temperature integrity is verified or assumed. And in peptide stability, assumptions fail more often than they hold.

Third-Party Testing Protocols Determine Research Reproducibility

Every peptide supplier claims purity verification, but the Selank Amidate price gap between $58 vials and $78 vials reflects whether testing is internal (supplier runs their own HPLC and reports the results they choose) or third-party (independent lab conducts analysis and issues a certificate with traceable accreditation). Internal testing allows selective reporting. Running five analyses, discarding two low results, and averaging the best three to report 97.8% purity when the true batch mean is 94.2%. Third-party COA from accredited labs (ISO/IEC 17025 certified) provides method validation, instrument calibration records, and analyst signature with date. Documentation required for publication-quality research and institutional compliance.

Real Peptides submits every Selank Amidate batch to independent analysis including HPLC purity determination, mass spectrometry for molecular weight confirmation, and endotoxin quantification via Limulus amebocyte lysate (LAL) assay. The COA includes chromatogram overlays showing target peak integration and impurity profile, mass spec data confirming M+H ion within 0.5 daltons of theoretical mass (919.02 for Selank Amidate), and endotoxin results typically <0.05 EU/mg. Well below the FDA guidance limit of 0.5 EU/mg for research peptides. Suppliers offering Selank Amidate price under $60 rarely provide chromatograms or mass spec traces, relying instead on single-number purity claims with no supporting data. The $16–$22 cost difference funds actual analytical rigor, not marketing.

Batch-to-batch consistency matters equally. A supplier with 96% average purity but ±4% variation between batches creates reproducibility issues when multi-month studies span three different production lots. Our small-batch model keeps inter-batch variation below 1.2% for Selank Amidate purity, meaning protocols initiated in February 2026 and continued in September 2026 use peptides with functionally identical bioactivity. Large-scale production with monthly batch changeovers introduces 3–6% purity swings that researchers interpret as biological variability when the true source is supplier inconsistency. The information in this section is for research planning purposes. Analytical method selection and supplier verification should align with institutional standards and the specific demands of your protocol.

Selank Amidate Price: Supplier Comparison

Understanding how Selank Amidate price correlates with verifiable quality markers helps labs allocate research budgets toward suppliers that support reproducible outcomes rather than suppliers optimizing for lowest acquisition cost.

Supplier Tier	Price Range per 5mg Vial	Purity Verification	Cold Chain Documentation	Batch Traceability	Professional Assessment
Budget Overseas	$47–$58	Internal testing, no chromatogram provided	Ambient shipping or unverified cold packs	Lot number only, no COA	Lowest Selank Amidate price but highest protocol failure risk. Suitable only for preliminary dose-finding where reproducibility isn't critical
Mid-Tier Domestic	$62–$72	Third-party COA on request, HPLC purity reported	Cold pack shipping, no temperature verification	COA available but not included with shipment	Reasonable compromise for established protocols with wide therapeutic windows. Adequate for most non-publication work
Premium Verified	$76–$89	Mandatory third-party COA with chromatogram and mass spec	Temperature datalogger included, expedited shipping	Full batch documentation with synthesis date and analyst signature	Highest Selank Amidate price but only tier supporting publication-quality reproducibility. Required when data integrity determines funding continuation

Real Peptides operates in the premium verified tier because institutional research and peer-reviewed publication demand documentation that budget suppliers cannot provide. The Selank Amidate price at $78 per 5mg vial includes third-party COA, temperature-verified shipping, and direct access to our quality team when protocols require specific stability data or custom reconstitution guidance. Researchers can also explore complementary nootropic compounds like P21 and Semax Amidate Peptide to understand how our commitment to synthesis precision extends across cognitive enhancement research peptides.

What If: Selank Amidate Price Scenarios

What If the Selank Amidate Price Seems Too Low Compared to Competitors?

Request the third-party COA and verify it includes HPLC chromatogram, mass spec data, and independent lab contact information. Not just a purity percentage on company letterhead. Selank Amidate price below $55 per vial almost always reflects compromised synthesis, skipped verification steps, or degraded cold chain, meaning the peptide you receive won't match labeled specifications regardless of what the supplier claims. Budget pricing works for preliminary screening where reproducibility matters less than throughput, but any protocol generating publication-bound data or regulatory submissions requires verified-tier suppliers where Selank Amidate price reflects actual analytical rigor. If the supplier cannot provide traceable third-party documentation within 48 hours of request, the low price reflects absent quality infrastructure rather than operational efficiency.

What If Selank Amidate Arrives and the Powder Looks Discolored or Clumped?

Do not reconstitute or use the peptide. Visual aggregation or yellow/brown discoloration indicates oxidation, moisture contamination, or temperature-induced degradation that renders purity claims meaningless. Lyophilised Selank Amidate should appear as a white to off-white fine powder with no visible clumping when the vial is gently tapped. Contact the supplier immediately with photos and request replacement alongside temperature verification records from the shipment. Reputable suppliers include temperature datalogger stickers that provide visual confirmation of cold chain integrity. If the sticker shows excursion above 8°C, the peptide degraded in transit regardless of synthesis quality. At Real Peptides, we replace temperature-compromised shipments at no cost because we control cold chain from synthesis to delivery, and our Selank Amidate price includes that accountability rather than treating it as an optional service upgrade.

What If Research Protocols Require Selank Amidate in Larger Quantities Than 5mg Vials?

Bulk orders of 10+ vials typically qualify for 8–12% volume pricing reduction, lowering per-vial Selank Amidate price to $68–$74 range while maintaining identical quality and documentation standards. Institutional labs should request lot reservation to ensure all vials in a multi-month study come from a single synthesis batch, eliminating inter-batch variability as a confounding variable in longitudinal protocols. Real Peptides accommodates lot reservation requests for orders of 15+ vials with advance notice, guaranteeing that June 2026 peptide and November 2026 peptide share identical synthesis date, purity, and COA documentation. Volume pricing never compromises synthesis method or verification protocols. The cost reduction reflects packaging and administrative efficiency, not reduced testing. Labs requiring custom concentrations or alternative formulations should contact suppliers directly, as many premium-tier providers offer custom synthesis at 20–30% above standard Selank Amidate price for batch sizes of 50+ vials.

What If the COA Shows Lower Purity Than Expected After Purchase?

Verify that the COA lot number matches the vial label lot number. Mix-ups occur when suppliers issue generic documentation rather than batch-specific analysis. If the lot numbers match and purity is 2–4% below the advertised specification, request a refund or replacement and document the discrepancy for institutional procurement records. Purity claims should match COA results within ±1%, and any supplier with consistent 3%+ discrepancies between marketing claims and actual testing lacks quality control systems required for research-grade supply. Real Peptides guarantees Selank Amidate purity of 96–98% as verified by third-party analysis, and the COA included with your shipment reflects the exact vial you received. Not a representative sample from a different production run. The slightly higher Selank Amidate price compared to budget suppliers funds the traceability infrastructure that makes this guarantee enforceable rather than aspirational.

The Uncomfortable Truth About Selank Amidate Price

Here's the honest answer: if Selank Amidate price is your only decision criterion, you'll end up repeating failed protocols and attributing the problem to biological variability when the true cause is compromised peptide quality. The $25–$35 you save per vial buying from unverified suppliers costs 10× that amount in wasted researcher time, failed experiments, and irreproducible data that can't support publication. Labs focused exclusively on acquisition cost rather than total protocol cost consistently produce lower-quality research outcomes. Not because their methodology is flawed, but because the peptides they're using don't match the specifications they're documenting in materials and methods sections.

The bottom line: suppliers offering Selank Amidate below $58 per vial in 2026 are either cutting synthesis corners, skipping verification, or shipping without cold chain controls. There's no fourth option where they've discovered magical cost efficiency that every other supplier missed. Premium-tier pricing around $76–$82 per vial reflects what it actually costs to synthesize peptides at 96–98% verified purity, maintain −20°C storage and shipping, conduct third-party testing, and provide batch-traceable documentation. That price includes the infrastructure required for reproducible research. The kind that holds up under peer review and supports career advancement rather than generating retraction notices.

Real Peptides prices Selank Amidate Peptide at $78 per 5mg vial because that's what small-batch synthesis with mandatory third-party verification costs when you refuse to compromise on quality. We've watched researchers struggle with inconsistent results from budget suppliers, switch to verified peptides, and immediately see protocol reproducibility stabilize. The Selank Amidate price difference is real, the quality difference is measurable, and the research outcome difference is career-defining. Choose suppliers based on the data you need to generate, not the budget you want to preserve. One failed experiment costs more than a year of premium peptide purchases.

The Selank Amidate price you pay determines the research reliability you achieve. Verified synthesis, documented cold chain, third-party COA, and batch traceability aren't premium features. They're baseline requirements for peptides that perform as labeled. If your supplier can't provide all four, your protocols are built on assumptions that fail more often than they hold, and no amount of methodological precision compensates for compromised starting materials.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Selank Amidate features a C-terminal amide modification that extends biological half-life from 5–8 minutes (acetate form) to 25–30 minutes by preventing rapid carboxypeptidase degradation. This structural change allows intranasal and subcutaneous protocols to achieve sustained peptide exposure without requiring continuous infusion or frequent repeat dosing. The amidate modification adds $6–$9 to synthesis cost but enables research designs that require stable peptide levels over 20–40 minute windows, making it the preferred form for anxiolytic and nootropic mechanism studies where acetate’s rapid degradation confounds dose-response relationships.

A legitimate third-party COA for Selank Amidate must include HPLC chromatogram showing target peak integration and impurity profile, mass spectrometry data confirming molecular weight within 0.5 daltons of theoretical mass (919.02 Da for Selank Amidate), endotoxin quantification below 0.5 EU/mg, and independent lab accreditation number (ISO/IEC 17025 certification). The COA should also list synthesis date, lot number matching the vial label, analyst signature, and direct lab contact information for verification. Suppliers providing only a purity percentage without supporting analytical data are issuing marketing documents rather than verifiable quality documentation.

Selank Amidate price variation reflects synthesis methodology (small-batch with intermediate verification vs large-scale batch processing), cold chain infrastructure (temperature-verified shipping vs ambient or unmonitored cold packs), testing protocols (third-party COA vs internal self-certification), and batch traceability systems. Suppliers at $47–$58 per vial typically skip intermediate HPLC during synthesis, ship without temperature monitoring, and provide generic purity claims without verifiable documentation. Premium suppliers at $76–$89 per vial include traceable third-party testing, mandatory cold chain verification, and batch-specific COA — the price difference funds quality infrastructure rather than arbitrary markup.

No — lyophilised Selank Amidate requires storage at −20°C even in unopened vials to prevent slow hydrolytic degradation and methionine oxidation that reduces purity by 3–6% over 6–12 months at room temperature. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days for >95% potency retention. Any temperature excursion above 8°C during storage or shipping accelerates peptide aggregation and degradation, causing irreversible loss of bioactivity that neither appearance nor basic testing can detect. Suppliers shipping without cold chain verification deliver peptides that have already undergone partial degradation regardless of synthesis quality.

Purity claims without verifiable third-party documentation are meaningless — overseas suppliers frequently report 96–98% purity based on internal testing that’s never independently confirmed, and international shipping introduces 10–21 day ambient or poorly controlled cold chain exposure that degrades peptides before arrival. Domestic suppliers with third-party COA and temperature-verified shipping provide traceable quality documentation and peptides that haven’t spent three weeks in customs warehouses at unknown temperatures. The lower Selank Amidate price from overseas sources reflects absent verification infrastructure and compromised distribution conditions, not equivalent quality at better pricing.

Verified cold chain shipping adds approximately $11–$14 per order but prevents the single most common cause of peptide degradation — temperature excursions during transit that reduce post-reconstitution stability by 40–50%. Lyophilised peptides exposed to temperatures above 8°C during shipping undergo irreversible aggregation and oxidation that compromises research reproducibility even when the peptide appears normal upon arrival. Temperature datalogger stickers provide visual confirmation of cold chain integrity throughout delivery, documenting that the peptide maintained required storage conditions from synthesis facility to lab receipt. Skipping cold chain verification to reduce Selank Amidate price is false economy — the cost savings disappear when protocols fail due to degraded starting materials.

Publication-quality research protocols typically require peptides with ≥96% purity verified by third-party HPLC analysis and molecular weight confirmation via mass spectrometry. Purity below 94% introduces sufficient impurities (deletion sequences, acetylated variants, oxidized forms) to confound dose-response relationships and reduce reproducibility below peer-review standards. Batch-to-batch variation should remain below 1.5% to support multi-month studies without introducing supplier inconsistency as a confounding variable. Most journals require materials and methods sections to document peptide purity and supplier verification method — unverified purity claims from suppliers lacking third-party COA will not satisfy reviewer scrutiny.

Synthesis method determines not just final purity but also impurity profile composition — peptides synthesized without intermediate coupling verification contain deletion sequences and truncated chains that dilute bioactivity differently than oxidized or acetylated variants. Two Selank Amidate batches both testing at 95% purity can produce different research outcomes if one contains 5% deletion sequences (low bioactivity impurities) and the other contains 5% oxidized methionine (potentially bioactive impurities with different receptor affinity). Small-batch synthesis with step-wise HPLC verification minimizes deletion sequences and produces consistent impurity profiles between batches, supporting reproducibility even when absolute purity varies slightly. The Selank Amidate price premium for verified synthesis funds this consistency rather than just higher percentage purity.

No — freeze-thaw cycles cause peptide aggregation and precipitation that permanently reduces bioavailability and creates inconsistent dosing even after the solution returns to apparent clarity. Once reconstituted with bacteriostatic water, Selank Amidate maintains >95% potency for 28 days when refrigerated continuously at 2–8°C, but refreezing introduces ice crystal formation that disrupts peptide structure and creates insoluble aggregates. Protocols requiring longer stability windows should use smaller reconstitution volumes or multiple vials rather than attempting to extend single-vial use through freezing. The 28-day refrigerated stability window reflects actual stability data from accelerated degradation studies, not arbitrary supplier recommendation.

Request the third-party COA for the current batch in stock and verify it includes HPLC chromatogram, mass spec data, and independent lab accreditation. Ask whether shipments include temperature datalogger verification and what the replacement policy is for temperature-compromised deliveries. Confirm whether the stated purity reflects internal testing or third-party analysis, and whether batch-to-batch documentation is available for longitudinal studies requiring lot reservation. Ask for synthesis date and expected remaining shelf life at time of delivery — peptides synthesized more than 6 months prior lose 2–4% purity even under ideal storage. Suppliers unable to provide specific answers to these questions lack the quality infrastructure required for research-grade peptide supply regardless of their stated Selank Amidate price.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA